V H Freedman - JoVE Visualize

Showing results (11-20 of 19) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 19 results.

The Journal of Experimental Medicine|July 1, 1984

Bacillus Calmette-Guérin-activated murine macrophages kill syngeneic melanoma cells under strict anaerobic conditionsV H Freedman, T E Gorrell, C F Nathan, et al.

AIDS Research and Human Retroviruses|August 10, 1997

The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virusP Haslett, M Hempstead, C Seidman, et al.

Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 1, 1997

Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosisA L Moreira, L Tsenova-Berkova, J Wang, et al.

Infection and Immunity|January 1, 1997

Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in miceP Laochumroonvorapong, J Wang, C C Liu, et al.

AIDS Research and Human Retroviruses|July 1, 1997

Thalidomide and thalidomide analogs reduce HIV type 1 replication in human macrophages in vitroA L Moreira, L G Corral, W Ye, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 1, 1989

A human immunoglobulin G receptor exists in both polypeptide-anchored and phosphatidylinositol-glycan-anchored formsB J Scallon, E Scigliano, V H Freedman, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 26, 2001

Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /betaC Manca, L Tsenova, A Bergtold, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 3, 1999

Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolatesC Manca, L Tsenova, C E Barry, et al.

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1996

The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infectionJ D Klausner, S Makonkawkeyoon, P Akarasewi, et al.

Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 19 results.

The Journal of Experimental Medicine|July 1, 1984

Bacillus Calmette-Guérin-activated murine macrophages kill syngeneic melanoma cells under strict anaerobic conditionsV H Freedman, T E Gorrell, C F Nathan, et al.

AIDS Research and Human Retroviruses|August 10, 1997

The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virusP Haslett, M Hempstead, C Seidman, et al.

Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 1, 1997

Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosisA L Moreira, L Tsenova-Berkova, J Wang, et al.

Infection and Immunity|January 1, 1997

Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in miceP Laochumroonvorapong, J Wang, C C Liu, et al.

AIDS Research and Human Retroviruses|July 1, 1997

Thalidomide and thalidomide analogs reduce HIV type 1 replication in human macrophages in vitroA L Moreira, L G Corral, W Ye, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 1, 1989

A human immunoglobulin G receptor exists in both polypeptide-anchored and phosphatidylinositol-glycan-anchored formsB J Scallon, E Scigliano, V H Freedman, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 26, 2001

Journal of Immunology (Baltimore, Md. : 1950)|June 3, 1999

Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolatesC Manca, L Tsenova, C E Barry, et al.

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1996

The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infectionJ D Klausner, S Makonkawkeyoon, P Akarasewi, et al.

Pageof 2